NASDAQ: JSPR
Jasper Therapeutics Inc Stock Ownership - Who owns Jasper Therapeutics?

Insider buying vs selling

Have Jasper Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Svetlana LucasDirector2025-09-2220,000$2.43
$48.60kBuy
Ron MartellPresident and CEO2025-09-2241,000$2.43
$99.63kBuy
Judith Anne ShizuruDirector2025-09-2241,000$2.43
$99.63kBuy
Thomas G. WiggansDirector2025-09-2241,000$2.43
$99.63kBuy

1 of 1

JSPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JSPR insiders and whales buy or sell their stock.

JSPR Shareholders

What type of owners hold Jasper Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roche Holding Ltd32.78%9,174,212$16.15MInsider
Qiming Us Healthcare Fund II LP30.44%8,519,648$14.99MInsider
Barney A. Richmond23.10%6,464,048$11.38MInsider
Kurt Von Emster20.19%5,649,733$9.94MInsider
Abingworth LLP20.11%5,628,558$9.91MInsider
Velan Capital Investment Management LP9.54%2,668,395$4.70MInstitution
Howard I. Hoffen8.22%2,300,000$4.05MInsider
Amplitude Healthcare Holdings LLC8.22%2,300,000$4.05MInsider
Balaji Venkataraman8.22%2,300,000$4.05MInsider
Kenneth F. Clifford8.22%2,300,000$4.05MInsider

1 of 3

JSPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JSPR29.25%70.75%Net Buying
LITS27.59%50.39%Net SellingNet Selling
IOBT13.75%69.82%Net Buying
KZIA0.02%2.75%
IBO0.51%2.02%Net Selling

Jasper Therapeutics Stock Ownership FAQ

Who owns Jasper Therapeutics?

Jasper Therapeutics (NASDAQ: JSPR) is owned by 72.03% institutional shareholders, 174.25% Jasper Therapeutics insiders, and 0.00% retail investors. Roche Holding Ltd is the largest individual Jasper Therapeutics shareholder, owning 9.17M shares representing 32.78% of the company. Roche Holding Ltd's Jasper Therapeutics shares are currently valued at $16.15M.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.